SLO-PHYLLIN Drug Patent Profile
When do Slo-phyllin patents expire, and when can generic versions of Slo-phyllin launch?
Slo-phyllin is a drug marketed by Sanofi Aventis Us and is included in six NDAs.
The generic ingredient in SLO-PHYLLIN is theophylline. There is one drug master file entry for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Slo-phyllin
A generic version of SLO-PHYLLIN was approved as theophylline by RHODES PHARMS on September 1st, 1982.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SLO-PHYLLIN?
- What are the global sales for SLO-PHYLLIN?
- What is Average Wholesale Price for SLO-PHYLLIN?
Summary for SLO-PHYLLIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 163 |
| Patent Applications: | 3,385 |
| DailyMed Link: | SLO-PHYLLIN at DailyMed |
US Patents and Regulatory Information for SLO-PHYLLIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | SLO-PHYLLIN | theophylline | CAPSULE, EXTENDED RELEASE;ORAL | 085206-001 | May 24, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sanofi Aventis Us | SLO-PHYLLIN | theophylline | SYRUP;ORAL | 085187-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sanofi Aventis Us | SLO-PHYLLIN | theophylline | CAPSULE, EXTENDED RELEASE;ORAL | 085203-001 | May 24, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sanofi Aventis Us | SLO-PHYLLIN | theophylline | CAPSULE, EXTENDED RELEASE;ORAL | 085205-001 | May 24, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sanofi Aventis Us | SLO-PHYLLIN | theophylline | TABLET;ORAL | 085204-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sanofi Aventis Us | SLO-PHYLLIN | theophylline | TABLET;ORAL | 085202-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
